Medical Devices & Pharma Earnings: Boston Scientific, Gilead, Stryker

124 views
  • About
  • Add to
Boston Scientific (BSX) said late yesterday that its third quarter profit totaled $190 million, or $0.12 per share, compared to a loss of $94 million, or $0.06 per share, in the same quarter last year. Revenue dipped 5%, to $1.92 billion.

0 comments